Skip to main content
Atrás
Watch Compare

IMPACT BIOMEDICAL INC.

Calidad de datos: 100%
IBO
NYSE Manufacturing Chemicals
$0.69
▼ $0.02 (-3.24%)
Cap. Mercado: 74.12 M
Precio
$0.69
Cap. Mercado
74.12 M
Rango del Día
$0.65 — $0.71
Rango de 52 Semanas
$0.36 — $1.95
Volumen
96,088
Apertura $0.66
Promedio 50D / 200D
$0.51
35.00% above
Promedio 50D / 200D
$0.57
21.49% above

Quick Summary

Puntos Clave

Negative free cash flow of -1.89 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
N/A
ROICN/A
Net Margin-36993.75%
Op. Margin-13381.25%

Seguridad

Debt / Equity
N/A
Current Ratio0.04
Interest Coverage-5.40

Valoración

PE (TTM)
-6.26
Below sector avg (-1.47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -6.3 -1.5
P/B — 1.6
ROE % — -53.5
Net Margin % -36993.8 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) -20.00%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 32,000.0 Net Income (TTM) -11.84 M
ROE N/A ROA -63.53%
Gross Margin N/A Operating Margin -13381.25%
Net Margin -36993.75% Free Cash Flow (TTM) -1.89 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.04
Interest Coverage -5.40 Asset Turnover 0.00
Working Capital -22.88 M Tangible Book Value -54.18 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -6.26 Forward P/E N/A
P/B Ratio N/A P/S Ratio 2316.13
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -2.55%
Market Cap 74.12 M Enterprise Value 74.10 M
Per Share
EPS (Diluted TTM) -0.38 Revenue / Share 0.00
FCF / Share -0.02 OCF / Share -0.02
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 15.97%
SBC-Adj. FCF -1.90 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023
Revenue 32,000.0 — 50,000.0
Net Income -11.84 M -24.71 M -4.41 M
EPS (Diluted) -0.38 -2.30 -0.07
Gross Profit — — —
Operating Income -4.28 M -28.75 M -4.03 M
EBITDA — — —
R&D Expenses 340,000.0 278,000.0 1.15 M
SG&A Expenses 873,000.0 718,000.0 315,000.0
D&A 1.15 M 1.12 M 1.12 M
Interest Expense 793,000.0 1.07 M 444,000.0
Income Tax -2.58 M 33,000.0 -621,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023
Total Assets 17.41 M 20.29 M 44.63 M
Total Liabilities 1.85 M 13.05 M 16.37 M
Shareholders' Equity 12.61 M 4.26 M 25.22 M
Total Debt — — —
Cash & Equivalents 3,000.0 2.00 M 1,000.0
Current Assets 411,000.0 2.45 M 332,000.0
Current Liabilities 1.16 M 9.79 M 13.14 M